InflaRx NV buy Lifesci Capital
Start price
05.04.23
/
50%
€5.34
Target price
05.04.24
-
Performance (%)
-73.58%
End price
06.04.24
€1.41
Summary
This prediction ended on 06.04.24 with a price of €1.41. Massive losses of -73.58% were the result for the BUY prediction by Lifesci_Capital. Lifesci_Capital has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| InflaRx NV | 17.930% | 17.930% | 13.557% | -75.158% |
| iShares Core DAX® | 3.023% | 2.202% | 14.664% | 48.878% |
| iShares Nasdaq 100 | 3.561% | 1.325% | 31.410% | 83.744% |
| iShares Nikkei 225® | 6.618% | 5.707% | 49.420% | 60.392% |
| iShares S&P 500 | 2.635% | 1.008% | 25.116% | 61.272% |
Comments by Lifesci_Capital for this prediction
In the thread InflaRx NV diskutieren
InflaRx (NASDAQ: IFRX) was upgraded by analysts at Lifesci Capital from a "market perform" rating to an "outperform" rating.
Ratings data for IFRX provided by MarketBeat
In the thread Trading InflaRx NV
Die von Lifesci_Capital gewählte maximale Laufzeit wurde überschritten